Changes in the Supervisory Board

MediClin pays a dividend of 5 cent per share for the 2008 financial year

Sales and occupancy rates increased – higher costs compared to previous year’s quarter

Asklepios increased the share in MediClin up to 20.2%

Management Board of Mediclin presents Annual Report 2008

In 2008 sales increased by nearly 65 million Euro through internal and external growth

Integrated medical care across medical sector borders gains more and more acceptance in the health care industry

MediClin AG: Capital increase successfully completed

MediClin has resolved upon a capital increase by utilization of authorized capital at the ratio of 2:1 at a subscription price per share of € 2.50

MediClin publishes first nine month figures of the 2008 financial year – further increase of occupancy